NCT06349486View on ClinicalTrials.gov

Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy for Hp Eradication

NARecruitingINTERVENTIONAL
Enrollment

780

Participants

Timeline

Start Date

November 28, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Helicobacter Pylori Eradication
Interventions
DRUG

vonoprazan, amoxicillin, tripotassium dicitrate bismuthate

bismuth-amoxicillin-vonoprazan triple therapy

DRUG

vonoprazan, amoxicillin

vonoprazan-amoxicillin dual therapy

DRUG

rabeprazole, amoxicillin, clarithromycin

proton pump inhibitor-based standard triple therapy

Trial Locations (1)

807

RECRUITING

Kaohsiung Medical University Hospital, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Medical University

OTHER